[Bortezomib]

Dtsch Med Wochenschr. 2006 Feb 3;131(5):214-8. doi: 10.1055/s-2006-924951.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects
  • Boronic Acids / chemistry
  • Boronic Acids / therapeutic use*
  • Bortezomib
  • Cell Division / drug effects
  • Humans
  • Kidney Neoplasms / drug therapy
  • Leukemia / drug therapy
  • Lymphoma, Non-Hodgkin / drug therapy
  • Male
  • Multiple Myeloma / drug therapy
  • Prostatic Neoplasms / drug therapy
  • Protease Inhibitors / therapeutic use
  • Pyrazines / chemistry
  • Pyrazines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Boronic Acids
  • Protease Inhibitors
  • Pyrazines
  • Bortezomib